J Appl Physiol 95: 854-862, 2003;
doi:10.1152/japplphysiol.00205.2003
8750-7587/03 $5.00
HIGHLIGHTED TOPICS
Airway Hyperresponsiveness: From Molecules to Bedside
Invited Review: Understanding airway pathophysiology with computed tomograpy
Robert H. Brown1 and
Wayne Mitzner2
Departments of 2Environmental Health Sciences and
1Anesthesiology and Critical Care Medicine, Bloomberg
School of Public Health and School of Medicine, The Johns Hopkins University,
Baltimore, Maryland 21205
 |
ABSTRACT
|
|---|
Conventional pulmonary function tests are limited in the mechanistic
insight that they can provide by the fact that they can only provide average
measures of lung function. For example, a measurement of decreased expiratory
flow assessed with conventional spirometry could result from narrowed large
airways, narrowed small airways, closed airways, altered elasticity, or
regional heterogeneities in parenchyma or airways. To examine specific
mechanisms and pathology in the airways, a method is required that can
actually look at specific individual airways. Over the past decade, several
more direct methods of assessing specific mechanisms and structural
alterations in normal airways and airway pathology in asthma have become
available for such purposes. One such method is high-resolution computed
tomography (HRCT), a method that allows the study of multiple individual
airways during either contraction to closure or relaxation in real time, as
well as changes in airway size with changes in lung volume. Although other
imaging modalities have the potential to image airways in vivo, none presently
has the convenience and the accessibility coupled with the resolution required
to visualize the parenchymal airways in vivo. Although HRCT may never be
widely utilized for routine measurements or screening, because of radiation
exposure, cost issues, and a limited ability to follow changes over extended
time periods, the method has distinct and unique advantages in quantifying the
behavior of airways in vivo. In this mini-review, we focus on these
capabilities of HRCT by briefly reviewing highlights of experimental results
from several canine and human studies.
high-resolution computed tomography; asthma; airway narrowing; airway closure; deep inspiration
THE PATHOLOGICAL CHANGES IN the airways that contribute to
clinical asthma have not been completely elucidated. Measurements of lung
function commonly used to understand the pathophysiology associated with
asthma are the forced expiratory volume in 1 s (FEV1), the forced
vital capacity, and the ratio of the two. Thus airway pathology in asthma is
assessed indirectly by measuring the amount and the speed with which air can
be exhaled. On one hand, it may be quite logical and appropriate to assess the
degree of the pathology by quantifying how easy or hard it is to get air out
of the lung. After all, a decreased ability to exhale is one of the hallmark
symptoms of asthma. On the other hand, however, quantifying the degree of
obstruction really tells us nothing about the mechanism of the underlying
pathology. A decreased flow could result from narrowed large airways, narrowed
small airways, closed airways, altered elasticity, or regional heterogeneities
in parenchyma or airways. Traditional pulmonary function tests can at best
provide only quantitative average measures of lung function. Although several
of these global tests of pulmonary function have been used to provide insight
into heterogeneity of ventilation, reasons for the local heterogeneities often
remain unclear. Even a more specific pulmonary function measurement such as
airway resistance will provide neither any insight into where the airway
obstruction might be nor any insight into how large the regional heterogeneity
in airway size might be. To examine specific mechanisms and pathology in the
individual airways, a method is required that can actually look at specific
individual airways.
Over the past decade, several direct methods of assessing airway pathology
in asthma have been used. One such method is high-resolution computed
tomography (HRCT) to visualize airway size in vivo. Although other imaging
modalities have the potential to image airways in vivo, none presently has the
convenience, the accessibility, and the resolution required to visualize the
airways. HRCT allows the study of multiple individual airways during
contraction to closure and relaxation in real time, as well as allowing study
of changes in airway size with changes in lung volume in animals
(8,
12,
18,
20) and in human subjects
(5,
7,
17,
47,
53). There are no other
methods that allow this kind of insight or investigation of airway behavior in
vivo. In the following sections, we will document the capabilities of HRCT by
briefly reviewing experimental results from several canine and human
studies.
 |
HETEROGENEITY OF AIRWAY RESPONSIVENESS
|
|---|
Pulmonary function tests of the whole lung provide an average of what all
the airways are doing. In a lung with several thousand conducting airways, it
is obvious that there must be some distribution, not only of the level of
baseline tone but also of the responsiveness to extrinsic challenges. This is
not an easy problem to resolve, even with the ability of HRCT to view
individual airways (13).
A key variable in any measure of airway responsiveness is the initial size
of the airway. It clearly will take much less shortening of airway smooth
muscle to cause a given change in airway resistance when the airway starts
from a smaller size. This effect is often neglected in assessment of airway
reactivity; however, using HRCT, we have observed substantial variability in
the baseline size of individual airways over extended periods of time. Because
we establish anatomic landmarks in each dog, it is straightforward to find the
same airway on any particular experimental day. We have followed these
baseline changes in dogs over the course of
1 yr
(18). These results show a
surprising degree of airway variability in the individual airways over this
extended time period. Within an animal, an individual airway sometimes seemed
to show random variation, whereas on other dates most of the airways appeared
to change similarly. We also found no correlation between the magnitude of
variability in an individual airway and its location (right vs. left, anterior
vs. posterior, and proximal vs. distal) within the lung. Additionally, the
mode of challenge was also shown to be unimportant
(9). We know of no comparable
in vivo studies that examine the changes in individual airway size over time.
There are studies in humans and dogs that have shown reproducibility of
traditional pulmonary function tests over time
(24,
45,
52). However, these
measurements reflect a summation of hundreds or thousands of airways. Indeed,
if we did a simple average of all the airway areas measured in each dog, we
also found no significant changes over time in this mean. Thus mean values or
global pulmonary function measurements provide no insight into the extent of
individual airway variability. Although we still do not know the reasons for
this underlying variability, the only way to study such a potentially
important phenomenon is with functional imaging.
The ability of HRCT to pursue this investigation is shown in
Fig. 1.
Figure 1 shows the variability
in baseline size of individual airways in five dogs, studied on two occasions,
each separated by at least 2 wk. Airway size is presented as a percentage of
each airway's maximally relaxed size, determined at the end of all experiments
on each experimental day. This maximal size was shown to be constant over
several months. As can be appreciated from
Fig. 1, the range of baseline
sizes can be quite large, with some airways residing near maximum and others
near closure even within the same animal. The variability within an animal is
as large as that between animals. Although heterogeneity of ventilation and
perfusion have been examined in increasing detail, examination of
heterogeneity in the anatomic and physiological functions of individual
airways is still in its infancy, but there is substantial evidence suggesting
that the pathology in asthmatic lungs is quite heterogeneous
(38,
49). How this normal airway
variability impacts on individual airway responsiveness and asthma remains to
be determined.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1. Plot of baseline airway area measurements as a percentage of maximally
relaxed size in individual airways in 5 dogs on 2 separate occasions
(A and B)23 wk apart. Symbols for individual airways
correspond to the same airway in each dog. There is some consistency over this
time period in some dogs (e.g., dog 4 has relatively dilated airways
and dog 2 is moderately constricted). Dog 1 shows an extreme
variability, with most airways quite constricted (one airway almost closed) on
the first day and several airways fully dilated on the next. [From Brown et
al. (13), with
permission.]
|
|
 |
MAXIMAL CONTRACTION
|
|---|
HRCT can be used to follow the time course of airway contraction to the
limits of its resolution (
0.5 mm lumen). We
(14) have used this potential
to document effective airway closure in response to a spasmogen. This
observation of a closure in vivo is consistent with in vitro airway
experiments, in which the airways do not generally exhibit a plateau effect to
an agonist challenge but continue to constrict to increasing concentrations of
agonist until complete closure occurs
(1,
25). Although airway closure
can also sometimes be observed in vivo
(60) and in situ
(44) as well as in vitro,
these observations are in direct conflict with indirect measurements of airway
narrowing in vivo with commonly used pulmonary function tests such as
FEV1 or airway resistance. With these conventional global
measurements, there appears to be a plateau in the response. We have
interpreted these contrary results by concluding that any apparent limitation
in airway responses in vivo must be due to mechanisms not directly related to
limitations associated with airway smooth muscle contraction. The appearance
of a plateau in vivo (26,
43,
50,
59,
63) may result from elastic
loads provided by the surrounding lung parenchyma or by limitations in the
delivery of agonist to the airway smooth muscle. To investigate this question
of maximal narrowing in individual airways in vivo, HRCT was used to visualize
canine airways narrowed by two routes of agonist challenge. Airway narrowing
induced by methacholine (MCh) via the conventional aerosol route was compared
with that caused by local atomization of MCh directly to individual airways.
Local atomization of microboluses of agonist were delivered directly to the
epithelium of the same airway locations measured during the conventional
aerosol challenge. The atomization was accomplished with a specially designed
catheter that could be placed with bronchoscopic visualization to deliver
agonist to a region smaller than 1 cm in the axial direction
(14).
Figures 2 and
3 demonstrate the localized
action of histamine on airway constriction.
Figure 2 shows a large
cartilaginous airway that has closed following local challenge.
Figure 3 shows the location of
the catheter tip and the degree of constriction as a function of distance
along the airway for three sequential increasing doses of histamine.
Figure 3 provides several
important insights into airway contraction in vivo. First,
Fig. 3 clearly supports our
ability to generate a very localized constriction with very little axial
spreading of the constriction. It was actually quite remarkable to observe
airway closure over a range of only a few millimeters, yet, just a few
millimeters either side of closure, the airways were nearly 50% of maximal
size. There is nothing in the literature that would have led to the prediction
that airway closure could occur over so limited a region. This result suggests
that there are few axial constraints limiting bronchoconstriction and that
severe airway obstruction in asthma might possibly result from relatively few
intense local effects.

View larger version (138K):
[in this window]
[in a new window]
|
Fig. 2. High-resolution computed tomography images of the same airway from one dog
demonstrating airway closure. Left arrow = fully relaxed airway after
atropine. Right arrow = absence of the airway lumen after
administration of 10 mg/ml of atomized methacholine (MCh). Bar = 10 mm. [From
Brown et. al. (14), with
permission.]
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3. One airway challenged with increasing concentrations of histamine. The
airway area is plotted as a function of distance from the catheter (in mm).
The airway narrowing was confined to a short distance, a few millimeters on
either side of the catheter tip. [From Brown et. al.
(14), with permission.]
|
|
Second, because this airway was
9 mm in diameter when there was no
smooth muscle tone, it clearly documents that there is no limitation on the
ability of any intraparenchymal airway to completely close in vivo. This
observation is consistent with in vitro experiments and supports the idea that
the apparent plateau often seen on aerosol dose-response curves in vivo may be
an artifact of the methodology because it clearly does not reflect the ability
of airway smooth muscle to completely overcome elastic loads in vivo.
What could be responsible for such artifacts? We do not have a definitive
answer, but, as shown in Fig.
4, even in our canine model, such apparent plateaus appear.
Although the dose-response curves give the appearance of a plateau, the airway
area continued to fall slightly even up to doses of 500 mg/ml. This value of
500 mg/ml was more than an order of magnitude greater than the largest doses
normally given to human subjects. It is not possible to challenge with aerosol
concentrations much above 500 mg/ml, both because solutions at higher
concentrations are not stable at room temperature and begin to precipitate
agonist and because systemic drug absorption can lead to cardiovascular
instability. However, a 10 mg/ml concentration of MCh delivered locally via
the catheter caused complete closure in 13 of 21 airways and extreme narrowing
in the remaining 8 airways (Fig.
3). In the airways not initially closed by the 10 mg/ml dose via
the catheter, the narrowing was comparable to that seen in the same airways at
the 500 mg/ml dose of aerosol MCh. When the 50 mg/ml dose of MCh was delivered
via the catheter to the eight airways that remained open after the initial 10
mg/ml dose, they also completely closed. Thus we think that the apparent
plateau seen with aerosol challenges may simply reflect a limited ability to
deliver higher doses to the airway smooth muscle.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4. Individual airway areas as a percentage of relaxed area after aerosol
(A) and local catheter (B) challenges plotted vs. MCh
concentration. Thirteen airways were completely closed after the 10 mg/ml dose
of MCh was delivered directly to the airway lumen via the atomization
catheter. The remaining 8 airways were closed after the 50 mg/ml dose. [From
Brown et. al. (14), with
permission.]
|
|
There has been extensive speculation about the interaction of the
parenchyma and the airways. Macklem
(39) has suggested that the
forces of interdependence of the parenchymal attachments on the airway wall
may be the cause of attenuated bronchoconstriction in vivo. This interaction
also highlights another difference between whole lung challenge and the local
challenge. In the whole lung challenge, the entire parenchyma is contracted as
well as the airway, and this could lead to increased tethering forces on the
airways. In an attempt to address this issue, we did another study to examine
the effects of increased mechanical distending stress on the airways caused by
increased positive end-expiratory pressure (PEEP) on preventing airway closure
was investigated (10).
Although the number of airways that remained open even with maximal
stimulation increased significantly when PEEP was increased, airway closure
still can occur even at the highest level of PEEP (P = 0.006). At 10
cmH2O, we found that 36% of the airways could still completely
close.
These results demonstrate that, whereas lung inflation can limit the
ability of airway smooth muscle to shorten, even relatively high levels of
PEEP could not always prevent airway closure when there was sufficient
stimulation to the airway smooth muscle. Increasing levels of PEEP shift the
MCh dose-response curve to the right, indicating an attenuation of airway
contraction by the increased lung inflation. The findings also put some
constraints on how effective the contracted parenchyma must be if that is to
play a role in limiting airway narrowing. The contracted parenchyma must
generate an effective peribronchial pressure of greater than 10
cmH2O if it is to be the mechanism that limits closure with aerosol
challenge. These results with PEEP also emphasize the heterogeneity in
individual airway responses. Whether repeat stimulation with the same degree
of lung inflation would close the same population of airways remains to be
determined. HRCT is the most accurate method with which to address this
question.
Both of these studies indicate that there is no limit to the ability of
smooth muscle to shorten in vivo. If these findings can be extrapolated to
humans, then several interpretations of these dose-response curves need to be
reconsidered. It is often assumed that normal subjects show a maximal
dose-response plateau, whereas asthmatic subjects do not
(43,
63). However, if there is no
limit of normal airways to narrow, then the difference only reflects a shift
in the dose-response curve to MCh and not a qualitative difference in the
degree of maximal shortening. We believe that if the airways were challenged
with the method we used in dogs normal human airways might be capable of
constricting to a much greater extent, with many airways even closing
completely.
 |
EFFECTS OF DEEP INSPIRATION ON AIRWAY CONSTRICTION
|
|---|
Deep inspirations (DIs) to total lung capacity (TLC) have been shown to
have both bronchoprotective (prevention of subsequent spasmogen-induced
bronchoconstriction) and bronchodilator (post-DI dilation of the airways)
effects in healthy subjects
(36,
54,
56). However, the effects of a
DI appear to be impaired in asthmatic subjects compared with healthy subjects.
When considering the effects of a DI, an implicit assumption is that all of
the airways are distending to their maximal size at TLC. However, we have
previously shown in a canine model that static distension of both relaxed and
contracted airways was not directly proportional to the lung inflation
(12). Fully relaxed airways
were quite distensible at low lung volume but quickly reached a maximal size
with no further distension up to TLC. With smooth muscle tone, the airways
showed variable degrees of dilation with lung inflation, but maximal
distension of moderately constricted airways was generally not achieved even
at TLC (12). Because the
ability to generate high transpulmonary pressures (Ptp) at TLC depends on both
lung properties and voluntary effort, we examined how the response of airways
to a DI might be altered if the maneuver was performed at less than maximal
inflation. Using HRCT, we examined the effects of varying Ptp during the DI
maneuver on subsequent airway caliber in anesthetized and ventilated dogs
during MCh infusion, a cholinergic spasmogen, and measured DI-induced changes
in airway size over the subsequent 5-min period
(11). Our results showed that
the magnitude of the Ptp to which the lung was inflated during the DI was
extremely important, leading to a qualitative change in the airway response.
These results are summarized in Fig.
5, which shows that the magnitude of lung inflation during a DI
has a major effect on the subsequent airway size. A large DI causes initial
airway distension and then a subsequent recovery back to near baseline size.
On the other hand, a small DI also causes initial airway distension but
subsequent airway constriction! In the work shown in
Fig. 5, distension of
MCh-contracted individual airways with tone would be expected to increase with
increasing peak inflation pressure but not necessarily achieve maximal
dilation even at the largest DI examined
(12). These previous
observations likely explain the smaller initial airway size at the first time
point following the inflation to TLC in
Fig. 5. However, the subsequent
bronchodilation or bronchoconstriction after the DI could not be predicted
from any previous work. With a DI to an airway pressure of 2535
cmH2O (corresponding to transpulmonary pressures of 1723
cmH2O), the airways showed a paradoxical constriction after release
of the DI.
Mechanisms underlying the observation in this study may have important
implications regarding human asthma. It is generally accepted that lung
inflation distends the airways of animals and humans
(12,
1517).
In airways with little smooth muscle tone, even moderate lung inflation
readily distends airways to their maximal size, and this was shown to be true
in experimental animal models even when airways were made edematous
(16,
19). Also, in normal healthy
human volunteers and mild asthmatic subjects, there were similar degrees of
airway distension at TLC either at baseline or after mildly increased airway
tone with aerosol MCh challenges
(17).
One mechanistic consideration involves the interaction between recoil
pressures of the airway smooth muscle and lung parenchyma following the DI. We
know that, at the lower inflation pressures, the airways are less dilated.
When the lung recoil pressure is decreased after the DI maneuver, this loss of
lung recoil may then lead to a further decrease in airway luminal size. It is
not entirely clear, however, why the paradoxical narrowing should take so long
to develop. This delay suggests perhaps that some intrinsic properties of the
smooth muscle contractile proteins might also be important. In a closely
related recent study (6),
shortening the time spent at maximal lung volume during a DI maneuver was
shown to lead to a subsequent paradoxical contraction of airways. Thus it
appears that, to obtain a normal airway dilation after a DI, one must
effectively dilate the airways to some minimal size, either by increasing the
peak inflation pressure or by lengthening the time at peak pressure. The
details of this pressure-time interaction are not yet clear, but as briefly
discussed below such a mechanism would seem to have considerable clinical
relevance.
Several recent clinical investigations have focused on single or repetitive
DIs as a means of preventing or reversing bronchoconstriction
(21,
40,
54,
55). In general, the nature of
the DIs in the clinical studies were not explicitly specified, but they were
usually brief and sigh-like, typically on the order of only a few seconds. The
above results may relate to the paradoxical airway narrowing sometimes seen in
asthmatic individuals after a DI
(3,
17,
21,
27,
28,
31,
48,
58,
62). Perhaps asthmatic airways
are stretched too little during the maneuver and behave like the low-pressure
groups in the present work.
 |
EFFECTS OF TIDAL STRETCH ON SUBSEQUENT RESPONSE OF AIRWAYS TO A
DI
|
|---|
To explain the absence in asthmatic individuals of a normal dilation
following a DI, Skloot et al.
(58) postulated first that
this resulted from an inability to dilate airways during the lung inflation to
TLC and second that this inability is a primary defect in asthma. Their study
(58) also showed that, with no
DIs during MCh challenge, normal subjects had a greatly exaggerated and
sustained response to this agonist. It was suggested that asthmatic airways
could be modeled by this situation. Recent experiments by Brusasco et al.
(21) and Brown et al.
(17), however, suggest that
there are more intrinsic differences between the responses to lung inflation
in airways from asthmatic and normal subjects. One of these factors may be the
influence of the normal tidal stretch on maintaining airway patency.
The effect of rhythmic cycling in decreasing the smooth muscle tone has
been shown in both in vitro
(33,
37) and in vivo studies
(22). Warner and Gunst
(61) originally demonstrated
that the rhythmic stretching associated with tidal breathing decreased not
only the baseline lung resistance but also the response to MCh. Gunst's group
later proposed a mechanistic explanation that involves changes in the
plasticity of the smooth muscle cellular cytostructure
(32,
57). Alternatively, in a
series of papers by Fredberg et al.
(29,
30), it was proposed that the
steady-state muscle force would be determined by a balance between high- and
low-energy cross-bridge dynamics and speculated that normal tidal breathing
would provide a sufficient stress to keep the low-energy state from occurring
in normal lungs.
We tested the validity of these in vitro models in an in vivo canine model
using HRCT (42). With the use
of a bronchial blocker, the right or left lung could be isolated and
selectively ventilated. One lung was then randomized for subsequent
ventilation. After 10 min of one-lung ventilation, both lungs were inflated to
30 cmH2O for 10 s; they were then allowed to passively expire to
functional residual capacity. This was repeated with the alternate lung
ventilated. After the 10-min period of ventilatory stasis in one lung, the
subsequent DI led to an increase in airway area in the ventilated lung and a
decrease in airway area of the unventilated lung. The correlations in
Fig. 6 show that, on the
ventilated side, lung volumes increased after a DI, concomitant with an
increase in the mean airway. On the nonventilated side, lung volume decreased
after a DI, concomitant with a decrease in mean airway area.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6. Correlation between the changes in airway area and (lung
volume)2/3 in the ventilated and nonventilated lungs before and
after DI. With respect to pre-DI measurements, on the ventilated side, lung
volume increased 65 ± 3% and mean airway area increased to 39 ±
2% after a DI (P = 0.0001). On the nonventilated side, lung volume
decreased 48 ± 2% and mean airway area decreased to 34 ± 2%
after a DI (P < 0.0001) [From Mitzner and Brown
(42), with permission.]
|
|
These results clearly demonstrate that the airway response to a DI could be
qualitatively changed by altering the pattern of normal tidal stresses. By
eliminating tidal stresses in one lung, we were able to change the normal
airway dilation that would occur in response to a DI to one of airway
constriction. This change occurred after tone was induced in the airways with
a continuous intravenous infusion of MCh. These observations are striking
because they provide a potential mechanism that allows conversion of the
normal airway dilation following a DI to that of constriction. All that was
needed to cause this qualitative change was to minimize the tidal stresses for
a period of time, which led to changes in the smooth muscle that now cause
constriction after the DI. Although this qualitative change in the response to
DI observed in the dog may well be related to the qualitative difference seen
between asthmatic and normal humans, the mechanisms underlying the observation
are still not completely clear. For example, the model of Fredberg et al.
(29) argued that the stresses
associated with normal tidal breathing were sufficient to keep the airway
smooth muscle from attaining a low-energy latch state. Whereas our results
appear to be consistent to what this model would predict, the situation in the
intact living lung is more complex than just the response of smooth muscle in
the airway wall. In situ, the final airway size depends on the resultant
recoil pressure exerted by the surrounding lung
(41). If the DI caused a
normal reduction in lung elastic recoil, but has little direct effect on a
stiff contracted airway, then the airway would end up smaller. Although
changes in asthmatic lungs may not mimic the experimental protocol used, air
trapping in the lungs of asthmatic subjects associated with bronchospasm could
lead to increased lung volume and altered tidal stresses on the airways and
parenchyma. Understanding the dose-time effect of these insidious changes may
ultimately affect the way asthma is managed and treated.
 |
AIRWAY DISTENSION IN HEALTHY AND MILD ASTHMATIC SUBJECTS
|
|---|
One explanation for the Skloot hypothesis, that a DI may be unable to
stretch the airways in asthmatic individuals, is an attenuation of the
tethering forces between the small airways and the surrounding parenchyma,
i.e., decreased interdependence
(36). Our laboratory
(17) used HRCT to examine the
ability of a DI to distend the airways of mildly asthmatic subjects, compared
with healthy subjects, at baseline and after increasing airway tone with
nebulized MCh. We found that, both at baseline and after the induction of
smooth muscle tone with MCh, a DI distended the airways of healthy and
asthmatic subjects to a similar extent, indicating that abnormal
interdependence between the lung parenchyma and the airways was unlikely to
play a major role in the loss or in the attenuation of the beneficial effect
of lung inflation that characterizes asthma. These finding differ from those
reported by Colebatch et al.
(23), who showed a substantial
difference in the distensibility of airways from asthmatic subjects. Reasons
for this difference are unclear but may be related to tissue dynamic
properties in their measurements of lung conductance or the severity of their
asthmatic population. In our study
(17), we also observed that,
after constriction had already been induced by MCh, a DI caused subsequent
bronchodilation in the healthy subjects but further bronchoconstriction in the
asthmatic subjects (Fig. 7).
These findings suggest that abnormal intrinsic properties of the airway smooth
muscle of mildly asthmatic subjects may counteract the bronchodilatory effect
of a DI.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 7. Average airway areas in 4 normal (open bars) and in 5 asthmatic (solid
bars) subjects at baseline functional residual capacity (FRC; 100%) after
bronchoconstriction with aerosol MCh, at total lung capacity (TLC; DI
maneuver) following the MCh challenge, and again, at FRC, after the TLC
maneuver. There was a significant increase in airway luminal area after the DI
in the healthy subjects compared with FRC after MCh (*P =
0.03). In contrast, there was a significant decrease in airway luminal area
after the DI in the asthmatic subjects compared with FRC after MCh
(**P < 0.0001). [Figure adapted from data in Brown et
al. (17).]
|
|
 |
AIRWAY REMODELING AND DISTENSION IN SEVERE ASTHMA
|
|---|
The mildly asthmatic subjects studied in the above protocol had normal
baseline pulmonary function. In the production of the symptoms of an acute
asthmatic attack, however, there is general acceptance that the degree of
severity in chronic asthma should be a function of airway caliber. Therefore,
the decrease in the baseline FEV1 with increasing severity should
be accompanied by decreasing luminal area. However, such a relationship has
not been demonstrated in most studies in which the relationship between
FEV1 and luminal area was examined,
(2,
4,
34,
38,
46), and at least one group
has expressed surprise that such a relationship has not been found
(46). We feel that one
explanation for this absent correlation is the confounding role of changes in
lung volumes on airway dimensions, a factor not generally taken into account.
With increasing severity, lung volume and elastic recoil pressure often change
in asthmatic patients, and the airway luminal area becomes larger as lung
volume increases. Because changes in TLC are not correlated with increasing
severity (35), HRCT
measurements of airway size at TLC may give insight into disease severity.
In ongoing work, we have attempted to address these issues in more severely
asthmatic subjects, in which there may be chronic changes altering both the
structure and distensibility of airways. Such changes should result in both
decreased baseline function and an inability to fully distend the airways at
TLC. We measured the ability of asthmatic subjects with varying degrees of
baseline airway obstruction to distend their airways with a DI. This
preliminary work shows that there is a significant decrease in airway
distensibility in the severely obstructed subjects compared with those with
either mild or moderate baseline obstruction (unpublished observations). Thus
asthmatic individuals with greater airflow obstruction do have a decreased
ability to distend their airways with lung inflation to TLC. Such compromised
airway distensibility could result from increased stiffness of the airways
from increased airway smooth muscle tone or secondary to airway remodeling and
deposition of nondistensible elements such as collagen in the airway wall
(51). Furthermore, although
the previous study suggested that decreased parenchymal interdependence may
not be important in mild asthma, it may assume increasing importance in the
severe condition.
This new work in humans has also found that there are structural changes in
airways that are consistent with decreased lung function even with no smooth
muscle tone (unpublished observations). These results show that decreased
FEV1 is correlated with smaller postalbuterol airway luminal area
at TLC. One reason that we can reveal this expected relationship between
luminal area and FEV1 is the ability of HRCT to measure the airway
areas at TLC. Further precision can also be achieved because the dimensions at
TLC used for the relationship to FEV1 were obtained after maximal
relaxation with albuterol, thereby minimizing the size variability associated
with different levels of baseline tone. This observation supports a
potentially key role of airway remodeling on asthma severity and further
supports this imaging methodology as a productive approach to examining the
role of remodeling on airway obstruction and asthma severity.
In summary, we have shown the unique ability of HRCT to quantify static and
dynamic changes in individual airways as small as 1 mm in diameter. Although
several new insights into airway behavior in vivo have been obtained with this
method, there are some clear limitations with its widespread use. Some of
these include the amount of radiation given to subjects, the cost, the
required supine position, and the inability to see the small membranous
airways. The most promising approach for future mechanistic studies may result
from combining HRCT with measurements of lung mechanics and classical
pulmonary function tests.
 |
FOOTNOTES
|
|---|
Address for correspondence: W. Mitzner, Division of Physiology, Bloomberg
School of Public Health, The Johns Hopkins Univ., 615 N. Wolfe St., Baltimore,
MD 21205 (E-mail:
wmitzner{at}jhsph.edu).
 |
REFERENCES
|
|---|
- Armour CL,
Black JL, Berend N, and Woolcock AJ. The relationship between bronchial
hyperresponsiveness to methacholine and airway smooth muscle structure and
reactivity. Respir Physiol 58:
223-233, 1984.
- Awadh N, Muller
NL, Park CS, Abboud RT, and FitzGerald JM. Airway wall thickness in
patients with near fatal asthma and control groups: assessment with high
resolution computed tomographic scanning. Thorax
53: 248-253,
1998.
- Beaupre A and
Orehek J. Factors influencing the bronchodilator effect of a deep
inspiration in asthmatic patients with provoked bronchoconstriction.
Thorax 37:
124-128, 1982.
- Beigelman-Aubry C, Capderou A, Grenier PA, Straus C, Becquemin MH,
Similowski T, and Zelter M. Mild intermittent asthma: CT assessment of
bronchial cross-sectional area and lung attenuation at controlled lung volume.
Radiology 223:
181-187, 2002.
- Boulet L,
Belanger M, and Carrier G. Airway responsiveness and bronchial-wall
thickness in asthma with or without fixed airflow obstruction. Am J
Respir Crit Care Med 152:
865-871, 1995.
- Brown RH.
Duration of deep inspiration and subsequent airway constriction in vivo.
J Asthma 40:
119-124, 2003.
- Brown RH,
Croisille P, Mudge B, Diemer FB, Permutt S, and Togias A. Airway narrowing
in healthy humans inhaling methacholine without deep inspirations demonstrated
by HRCT. Am J Respir Crit Care Med
161: 1256-1263,
2000.
- Brown RH,
Herold CJ, Hirshman CA, Zerhouni EA, and Mitzner W. In vivo measurements
of airway reactivity using high resolution computed tomography. Am
Rev Respir Dis 144:
208-212, 1991.
- Brown RH,
Herold CJ, Hirshman CA, Zerhouni EA, and Mitzner W. Individual airway
constrictor response heterogeneity assessed by high-resolution computed
tomography. J Appl Physiol 74:
2615-2620, 1993.
- Brown RH and
Mitzner W. Airway closure with high PEEP in vivo. J Appl
Physiol 89:
956-960, 2000.
- Brown RH and
Mitzner W. Airway response to deep inspiration: role of inflation
pressure. J Appl Physiol 91:
2574-2578, 2001.
- Brown RH and
Mitzner W. Effect of lung inflation and airway muscle tone on airway
diameter in vivo. J Appl Physiol
80: 1581-1588,
1996.
- Brown RH and
Mitzner W. Heterogeneity in airways. In: Complexity in
Structure and Function of the Lung, edited by Hlastala MP and
Robertson HT. New York: Dekker, 1998, p.
1-34.
- Brown RH and
Mitzner W. The myth of maximal airway responsiveness in vivo. J
Appl Physiol 85:
2012-2017, 1998.
- Brown RH,
Mitzner W, Bulut Y, and Wagner EM. Effects of lung inflation in vivo on
airways with smooth muscle tone or edema. J Appl
Physiol 82:
491-499, 1997.
- Brown RH,
Mitzner W, and Wagner EM. Interaction between airway edema and lung
inflation on responsiveness of individual airways in vivo. J Appl
Physiol 83:
366-370, 1997.
- Brown RH,
Scichilone N, Mudge B, Diemer FB, Permutt S, and Togias A. High-resolution
computed tomographic evaluation of airway distensibility and the effects of
lung inflation on airway caliber in healthy subjects and individuals with
asthma. Am J Respir Crit Care Med
163: 994-1001,
2001.
- Brown RH,
Zerhouni AE, and Mitzner W. Variability in the size of individual airways
over the course of one year. Am J Respir Crit Care Med
151: 1159-1164,
1995.
- Brown RH,
Zerhouni EA, and Mitzner W. Airway edema potentiates airway reactivity.
J Appl Physiol 79:
1242-1248, 1995.
- Brown RH,
Zerhouni EA, and Mitzner W. Visualization of airway obstruction in vivo
during lung vascular engorgement and edema. J Appl
Physiol 78:
1070-1078, 1995.
- Brusasco V,
Crimi E, Barisione G, Spanevello A, Rodarte JR, and Pellegrino R. Airway
responsiveness to methacholine: effects of deep inhalations and airway
inflammation. J Appl Physiol
87: 567-573,
1999.
- Bulut Y,
Hirshman CA, and Brown RH. Prevention of lidocaine aerosol-induced
bronchoconstriction with intravenous lidocaine.
Anesthesiology 85:
853-859, 1996.
- Colebatch HJ,
Finucane KE, and Smith MM. Pulmonary conductance and elastic recoil
relationships in asthma and emphysema. J Appl Physiol
34: 143-153,
1973.
- Dawson A.
Reproducibility of spirometric measurements in normal subjects. Am
Rev Respir Dis 93:
264-269, 1966.
- De Jongste JC,
Sterk PJ, Willems LN, Mons H, Timmers MC, and Kerrebijn KF. Comparison of
maximal bronchoconstriction in vivo and airway smooth muscle responses in
vitro in nonasthmatic humans. Am Rev Respir Dis
138: 321-326,
1988.
- Ding DJ, Martin
JG, and Macklem PT. Effects of lung volume on maximal methacholine-induced
bronchoconstriction in normal humans. J Appl Physiol
62: 1324-1330,
1987.
- Fish JE, Ankin
MG, Kelly JF, and Peterman VI. Regulation of bronchomotor tone by lung
inflation in asthmatic and nonasthmatic subjects. J Appl
Physiol 50:
1079-1086, 1981.
- Fish JE,
Peterman VI, and Cugell D. Effect of deep inspiration on airway
conductance in subjects with allergic rhinitis and allergic asthma.
J Allergy Clin Immunol 60:
41-46, 1977.
- Fredberg JJ,
Inouye D, Miller B, Nathan M, Jafari S, Raboudi S, Butler JP, and Shore
SA. Airway smooth muscle, tidal stretches and dynamically-determined
contractile states. Am J Respir Crit Care Med
156: 1752-1759,
1997.
- Fredberg JJ,
Jones KA, Raboudi NS, Prakash YS, Shore SA, Butler JP, and Sieck GC.
Friction in airway smooth muscle: mechanism, latch, and implications in
asthma. J Appl Physiol 81:
2703-2712, 1996.
- Gayrard P,
Orehek J, Grimaud C, and Charpin J. Bronchoconstrictor effects of a deep
inspiration in patients with asthma. Am Rev Respir Dis
111: 433-439,
1975.
- Gunst SJ, Meiss
RA, Wu MF, and Rowe M. Mechanisms for the mechanical plasticity of
tracheal smooth muscle. Am J Physiol Cell Physiol
268: C1267-C1276,
1995.
- Gunst SJ and
Mitzner W. Mechanical properties of contracted canine bronchial segments
in vitro. J Appl Physiol 50:
1236-1247, 1981.
- Harmanci E,
Kebapci M, Metintas M, and Ozkan R. High-resolution computed tomography
findings are correlated with disease severity in asthma.
Respiration 69:
420-426, 2002.
- Irvin CG.
Airway mechanics in asthma. In: Rhinitis and Asthma,
edited by Holgate ST. Boston, MA: Blackwell Scientific, 1995, p.
1033-1043.
- Kapsali T,
Permutt S, Laube B, Scichilone N, and Togias A. Potent bronchoprotective
effect of deep inspiration and its absence in asthma. J Appl
Physiol 89:
711-720, 2000.
- Kharitonov SA and Barnes PJ. Exhaled markers of pulmonary disease. Am J
Respir Crit Care Med 163:
1693-1722, 2001.
- Lutchen KR,
Jensen A, Atileh H, Kaczka DW, Israel E, Suki B, and Ingenito EP. Airway
constriction pattern is a central component of asthma severity: the role of
deep inspirations. Am J Respir Crit Care Med
164: 207-215,
2001.
- Macklem PT.
Mechanical factors determining maximum bronchoconstriction. Eur
Respir J 2, Suppl 6:
516s-519s, 1989.
- Malmberg P,
Larsson K, Sundblad BM, and Zhiping W. Importance of the time interval
between FEV1 measurements in a methacholine provocation test.
Eur Respir J 6:
680-686, 1993.
- Mead J,
Takishima T, and Leith D. Stress distribution in lungs: a model of
pulmonary elasticity. J Appl Physiol
28: 596-608,
1970.
- Mitzner W and
Brown RH. Potential mechanism of hyperresponsive airways. Am J
Respir Crit Care Med 161:
1619-1623, 2000.
- Moore BJ,
Hilliam CC, Verburgt LM, Wiggs BR, Vedal S, and Pare PD. Shape and
position of the complete dose-response curve for inhaled methacholine in
normal subjects. Am J Respir Crit Care Med
154: 642-648,
1996.
- Murtagh PS,
Proctor DF, Permutt S, Kelly B, and Evering S. Bronchial closure with
Mecholyl in excised dog lobes. J Appl Physiol
31: 409-415,
1971.
- Nickerson BG,
Lemen RJ, Gerdes CB, Wegmann MJ, and Robertson G. Within-subject
variability and per cent change for significance of spirometry in normal
subjects and in patients with cystic fibrosis. Am Rev Respir
Dis 122: 859-866,
1980.
- Niimi A,
Matsumoto H, Amitani R, Nakano Y, Mishima M, Minakuchi M, Nishimura K, Itoh H,
and Izumi T. Airway wall thickness in asthma assessed by computed
tomography. Relation to clinical indices. Am J Respir Crit Care
Med 162:
1518-1523, 2000.
- Okazawa M,
Muller N, McNamara AE, Child S, Verburgt L, and Pare PD. Human airway
narrowing measured using high resolution computed tomography. Am J
Respir Crit Care Med 154:
1557-1562, 1996.
- Orehek J,
Charpin D, Velardocchio JM, and Grimaud C. Bronchomotor effect of
bronchoconstriction-induced deep inspirations in asthmatics. Am Rev
Respir Dis 121:
297-305, 1980.
- Quan SF, Moon
MA, and Lemen RJ. Effects of arachidonic acid, PGF2
, and a PGH2
analogue on airway diameters in dogs. J Appl Physiol
53: 1005-1014,
1982.
- Robatto FM,
Simard S, Orana H, Macklem PT, and Ludwig MS. Effect of lung volume on
plateau response of airways and tissue to methacholine in dogs. J
Appl Physiol 73:
1908-1913, 1992.
- Roche WR,
Beasley R, Williams JH, and Holgate ST. Subepithelial fibrosis in the
bronchi of asthmatics. Lancet
1: 520-524,
1989.
- Rozas CJ and
Goldman AL. Daily spirometric variability: normal subjects and subjects
with chronic bronchitis with and without airflow obstruction. Arch
Intern Med 142:
1287-1291, 1982.
- Sasaki F,
Saitoh Y, Verburgt L, and Okazawa M. Airway wall dimensions during
carbachol-induced bronchoconstriction in rabbits. J Appl
Physiol 81:
1578-1583, 1996.
- Scichilone N,
Kapsali T, Permutt S, and Togias A. Deep inspiration-induced
bronchoprotection is stronger than bronchodilation. Am J Respir
Crit Care Med 162:
910-916, 2000.
- Scichilone N,
Permutt S, and Togias A. The lack of the bronchoprotective and not the
bronchodilatory ability of deep inspiration is associated with airway
hyperresponsiveness. Am J Respir Crit Care Med
163: 413-419,
2001.
- Scichilone N,
Pyrgos G, Kapsali T, Anderlind C, Brown R, Permutt S, and Togias A.
Airways hyperresponsiveness and the effects of lung inflation. Int
Arch Allergy Immunol 124:
262-266, 2001.
- Shen X, Wu MF,
Tepper RS, and Gunst SJ. Mechanisms for the mechanical response of airway
smooth muscle to length oscillation. J Appl Physiol
83: 731-738,
1997.
- Skloot G,
Permutt S, and Togias AG. Airway hyperresponsiveness in asthma: a problem
of limited smooth muscle relaxation with inspiration. J Clin
Invest 96:
2393-2403, 1995.
- Sterk PJ,
Timmers MC, and Dijkman JH. Maximal airway narrowing in humans in vivo
histamine compared with methacholine. Am Rev Respir
Dis 134: 714-718,
1986.
- Tepper RS,
Gunst SJ, Doerschuk CM, Shen X, and Bray W. Effect of transpulmonary
pressure on airway closure in immature and mature rabbits. J Appl
Physiol 78:
505-512, 1995.
- Warner DO and
Gunst SJ. Limitation of maximal bronchoconstriction in living dogs.
Am Rev Respir Dis 145:
553-560, 1992.
- Wheatley JR,
Pare PD, and Engel LA. Reversibility of induced bronchoconstriction by
deep inspiration in asthmatic and normal subjects. Eur Respir
J 2: 331-339,
1989.
- Woolcock AJ,
Salome CM, and Yan K. The shape of the dose-response curve to histamine in
asthmatic and normal subjects. Am Rev Respir Dis
130: 71-75,
1984.
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Lai-Fook, P. K. Houtz, and Y.-L. Lai
End-expiratory and tidal volumes measured in conscious mice using single projection x-ray images
J Appl Physiol,
February 1, 2008;
104(2):
521 - 533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Brown, D. B. Pearse, G. Pyrgos, M. C. Liu, A. Togias, and S. Permutt
The structural basis of airways hyperresponsiveness in asthma
J Appl Physiol,
July 1, 2006;
101(1):
30 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Musch and J. G. Venegas
Positron Emission Tomography Imaging of Regional Pulmonary Perfusion and Ventilation
Proceedings of the ATS,
December 1, 2005;
2(6):
522 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Tgavalekos, M. Tawhai, R. S. Harris, G. Mush, M. Vidal-Melo, J. G. Venegas, and K. R. Lutchen
Identifying airways responsible for heterogeneous ventilation and mechanical dysfunction in asthma: an image functional modeling approach
J Appl Physiol,
December 1, 2005;
99(6):
2388 - 2397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Deng, N. J. Fairbank, B. Fabry, P. G. Smith, and G. N. Maksym
Localized mechanical stress induces time-dependent actin cytoskeletal remodeling and stiffening in cultured airway smooth muscle cells
Am J Physiol Cell Physiol,
August 1, 2004;
287(2):
C440 - C448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Kjaergaard, O. F. Pedersen, M. R. Miller, T. R. Rasmussen, J. C. Hansen, and L. Molhave
Ozone exposure decreases the effect of a deep inhalation on forced expiratory flow in normal subjects
J Appl Physiol,
May 1, 2004;
96(5):
1651 - 1657.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Physiological Society.